Please assess the completion status of the following clinical trial:

Trial Title: Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Infants were eligible for the study if they were:~* 6-12 weeks postnatal age~* weighed more than 3 kg~* were after surgical repair for EA or CDH~* showed clinical GERD~* were to undergo the 48 hour pH measurements.~Infants were excluded if they were:~* allergic to omeprazole~* participated in other interventional trials~* used medications known to interact with omeprazole.

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 3 Months
- Healthy Volunteers: f

Study Arms:
- Oral omeprazole (Type: NO_INTERVENTION): Standard of care: A single dose of 1 mg/kg orally administered omeprazole.
- Rectal omeprazole (Type: ACTIVE_COMPARATOR): A single dose of 1 mg/kg rectally administered omeprazole.

Based on this trial design, predict the completion outcome and termination type (if applicable).